Status: Recruiting
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
This study is a multicenter, randomized, double-blind, placebo-controlled, superiority design Phase III clinical trial. The primary objective is to evaluate the efficacy and safety of cyclosporine ophthalmic gel versus placebo in the treatment of moderate to severe dry eye for 84 days.
Participants needed: 360
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Updated: Jul 28, 2025Locations: 1
Eligibility criteria
aged ≥ 18 years old, males or females. [+7]
Subjects with severe dry eye requiring surgical treatment. [+9]